Healthcare Innovations Trust II, 5
Back to All Primary TrustsPortfolio Holdings by Security (As of Deposit Date)
Ticker | Security Description | Deposit % |
---|---|---|
AGIO | Agios Pharmaceuticals, Inc. | 3.33 |
ARDX | Ardelyx, Inc. | 3.29 |
AVDL | Avadel Pharmaceuticals plc | 3.34 |
BCRX | BioCryst Pharmaceuticals, Inc. | 3.33 |
BHVN | Biohaven Ltd. | 3.28 |
CLDX | Celldex Therapeutics, Inc. | 3.27 |
ETNB | 89bio, Inc. | 3.37 |
GRFS | Grifols, S.A. | 3.25 |
IBRX | ImmunityBio, Inc. | 3.38 |
INCY | Incyte Corporation | 3.34 |
INDV | Indivior PLC | 3.35 |
IOVA | Iovance Biotherapeutics, Inc. | 3.31 |
JAZZ | Jazz Pharmaceuticals plc | 3.28 |
KALV | KalVista Pharmaceuticals, Inc. | 3.36 |
KURA | Kura Oncology, Inc. | 3.32 |
MDGL | Madrigal Pharmaceuticals, Inc. | 3.32 |
MGTX | MeiraGTx Holdings plc | 3.39 |
MLYS | Mineralys Therapeutics, Inc. | 3.3 |
NUVB | Nuvation Bio Inc. | 3.35 |
NVCR | NovoCure Limited | 3.29 |
ORGO | Organogenesis Holdings Inc. | 3.42 |
QURE | uniQure N.V. | 3.35 |
RARE | Ultragenyx Pharmaceutical Inc. | 3.31 |
RCKT | Rocket Pharmaceuticals, Inc. | 3.43 |
SNDX | Syndax Pharmaceuticals, Inc. | 3.4 |
SUPN | Supernus Pharmaceuticals, Inc. | 3.32 |
TEVA | Teva Pharmaceutical Industries Ltd. | 3.31 |
TVTX | Travere Therapeutics, Inc. | 3.37 |
URGN | UroGen Pharma Ltd. | 3.33 |
VERA | Vera Therapeutics, Inc. | 3.31 |
Health Care
Ticker | Security Description | Deposit % |
---|---|---|
ETNB | 89bio, Inc. | 3.37 |
AGIO | Agios Pharmaceuticals, Inc. | 3.33 |
ARDX | Ardelyx, Inc. | 3.29 |
AVDL | Avadel Pharmaceuticals plc | 3.34 |
BCRX | BioCryst Pharmaceuticals, Inc. | 3.33 |
BHVN | Biohaven Ltd. | 3.28 |
CLDX | Celldex Therapeutics, Inc. | 3.27 |
GRFS | Grifols, S.A. | 3.25 |
IBRX | ImmunityBio, Inc. | 3.38 |
INCY | Incyte Corporation | 3.34 |
INDV | Indivior PLC | 3.35 |
IOVA | Iovance Biotherapeutics, Inc. | 3.31 |
JAZZ | Jazz Pharmaceuticals plc | 3.28 |
KALV | KalVista Pharmaceuticals, Inc. | 3.36 |
KURA | Kura Oncology, Inc. | 3.32 |
MDGL | Madrigal Pharmaceuticals, Inc. | 3.32 |
MGTX | MeiraGTx Holdings plc | 3.39 |
MLYS | Mineralys Therapeutics, Inc. | 3.3 |
NVCR | NovoCure Limited | 3.29 |
NUVB | Nuvation Bio Inc. | 3.35 |
ORGO | Organogenesis Holdings Inc. | 3.42 |
RCKT | Rocket Pharmaceuticals, Inc. | 3.43 |
SUPN | Supernus Pharmaceuticals, Inc. | 3.32 |
SNDX | Syndax Pharmaceuticals, Inc. | 3.4 |
TEVA | Teva Pharmaceutical Industries Ltd. | 3.31 |
TVTX | Travere Therapeutics, Inc. | 3.37 |
RARE | Ultragenyx Pharmaceutical Inc. | 3.31 |
QURE | uniQure N.V. | 3.35 |
URGN | UroGen Pharma Ltd. | 3.33 |
VERA | Vera Therapeutics, Inc. | 3.31 |
Summary
Description
-
Trust Name Healthcare Innovations Trust II, 5
-
Trust Symbol STHCEX
-
ML Symbol STHI5
Deposit Data
-
Deposit Date 05/01/2025
-
Termination Date 20270429
-
Minimum Investment 100
-
Distribution Frequency Monthly (if any)
-
Initial Public Offer Price $10.00
-
Historical 12-Month Dist.* 0.0000
CUSIP
-
Cash Cusip 83207W700
-
Reinvest Cusip 83207W718
-
Fee Cash Cusip 83207W726
-
Fee Invest Cusip 83207W734
Documents
*The Historical 12-Month Distribution of Trust Holdings is as of 10/01/2024. If the Trust deposited after, or 90 days prior to, 10/01/2024, the distribution is as of deposit date. The Historical 12-Month Distribution is calculated by taking the weighted average of the regular income distributions paid by the securities included in the trust’s portfolio over the 12 months preceding the trust’s date of deposit reduced to account for the effects of trust fees and expenses. This historical distribution is for illustrative purposes only and is not indicative of amounts that will actually be distributed by the trust. The distributions paid by the trust may be higher or lower than the amount shown above due to factors including, but not limited to, changes in the price of trust units, changes (including reductions) in distributions paid by issuers, changes in actual trust expenses and sales of securities in the portfolio. There is no guarantee that the issuers of the securities included in the trust will pay any distributions in the future.